Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 27 of 27 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/04/22
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 01/26/24
End: 10/31/25
Due: 10/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| LAMBDA 002 (Lung Registry) Study | NCT05170425 | Natera, Inc. | user2@example.com | None | 2022-11-04 | 2027-05-31 | 2028-05-31 | - | - | 2025-07-14 |
| Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection | NCT06620627 | Natera, Inc. | user2@example.com | None | 2024-01-26 | 2025-10-31 | 2026-10-31 | - | - | 2025-07-14 |